123 related articles for article (PubMed ID: 6619626)
1. [Determination of malignancy of cartilaginous tumors (2). Determination of malignancy by nuclear DNA contents and their distribution patterns in cartilaginous tumors].
Lin CP; Higaki S; Takeyama S; Nakata T; Akai M; Tateishi A; Abe M
Nihon Seikeigeka Gakkai Zasshi; 1983 Jun; 57(6):617-28. PubMed ID: 6619626
[TBL] [Abstract][Full Text] [Related]
2. Cytophotometric studies of the nuclear DNA content in cartilaginous tumors.
Cuvelier CA; Roels HJ
Cancer; 1979 Oct; 44(4):1363-74. PubMed ID: 498016
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of cytofluorometric DNA ploidy analysis in distinguishing benign cartilaginous tumors from chondrosarcomas.
Kusuzaki K; Murata H; Takeshita H; Hirata M; Hashiguchi S; Tsuji Y; Nakamura S; Ashihara T; Hirasawa Y
Mod Pathol; 1999 Sep; 12(9):863-72. PubMed ID: 10496594
[TBL] [Abstract][Full Text] [Related]
4. The prognostic significance of nuclear DNA content in chondrosarcoma.
Kreicbergs A; Zetterberg A; Söderberg G
Anal Quant Cytol; 1980 Dec; 2(4):272-9. PubMed ID: 7469202
[TBL] [Abstract][Full Text] [Related]
5. Correlation between clinicopathological features and karyotype in 100 cartilaginous and chordoid tumours. A report from the Chromosomes and Morphology (CHAMP) Collaborative Study Group.
Tallini G; Dorfman H; Brys P; Dal Cin P; De Wever I; Fletcher CD; Jonson K; Mandahl N; Mertens F; Mitelman F; Rosai J; Rydholm A; Samson I; Sciot R; Van den Berghe H; Vanni R; Willén H
J Pathol; 2002 Feb; 196(2):194-203. PubMed ID: 11793371
[TBL] [Abstract][Full Text] [Related]
6. [DNA-ploidy and proliferation in metastatic neuroblastoma].
Böhm N; Lampert F
Klin Padiatr; 1982; 194(4):270-4. PubMed ID: 7132228
[TBL] [Abstract][Full Text] [Related]
7. Microspectrophotometric quantitation of DNA in bone tumors with giant cells (osteoclastoma, osteosarcoma and chondroblastoma).
Schajowicz F; Cabrini RL; Gimenez I
Clin Orthop Relat Res; 1981 May; (156):91-7. PubMed ID: 6939515
[TBL] [Abstract][Full Text] [Related]
8. Wide resection of primary tumors of bone and replacement with massive bone grafts: an improved technique for transplanting allogeneic bone grafts.
Koskinen EV
Clin Orthop Relat Res; 1978; (134):302-19. PubMed ID: 365415
[TBL] [Abstract][Full Text] [Related]
9. Comparative single-cell and flow DNA analysis of bone sarcoma.
Kreicbergs A; Cewrien G; Tribukait B; Zetterberg A
Anal Quant Cytol; 1981 Jun; 3(2):121-7. PubMed ID: 7020515
[TBL] [Abstract][Full Text] [Related]
10. [Cartilaginous tumors in children].
Dumontier C; Rigault P; Padovani JP; Touzet P; Finidori G; Mallet JF
Chir Pediatr; 1989; 30(2):91-7. PubMed ID: 2758534
[TBL] [Abstract][Full Text] [Related]
11. Flow cytometric determination of DNA content in malignant and benign bone tumours.
Heliö H; Karaharju E; Nordling S
Cytometry; 1985 Mar; 6(2):165-71. PubMed ID: 3979218
[TBL] [Abstract][Full Text] [Related]
12. Prognostic indicators including DNA histogram type, receptor content, and staging related to human breast cancer patient survival.
Coulson PB; Thornthwaite JT; Woolley TW; Sugarbaker EV; Seckinger D
Cancer Res; 1984 Sep; 44(9):4187-96. PubMed ID: 6744328
[TBL] [Abstract][Full Text] [Related]
13. Nuclear characterization and G2M ploidy in human brain tumors using semiautomated image analysis.
Yoshii Y; Saito A; Tsuboi K; Tsurushima H; Komatsu Y; Tomono Y; Hyodo A; Nose T
Noshuyo Byori; 1995 Mar; 12(1):61-7. PubMed ID: 7795731
[TBL] [Abstract][Full Text] [Related]
14. Comparative genomic hybridization in cartilaginous tumors.
Ozaki T; Wai D; Schäfer KL; Lindner N; Böcker W; Winkelmann W; Dockhorn-Dworniczak B; Poremba C
Anticancer Res; 2004; 24(3a):1721-5. PubMed ID: 15274346
[TBL] [Abstract][Full Text] [Related]
15. [Quantitative diagnosis and histopathologic grading of chondrosarcoma].
Li JP
Zhonghua Zhong Liu Za Zhi; 1993 Sep; 15(5):391-3. PubMed ID: 8174490
[TBL] [Abstract][Full Text] [Related]
16. Cell proliferation studies in primary synovial chondromatosis.
Davis RI; Foster H; Arthur K; Trewin S; Hamilton PW; Biggart DJ
J Pathol; 1998 Jan; 184(1):18-23. PubMed ID: 9582522
[TBL] [Abstract][Full Text] [Related]
17. DNA in situ sensitivity to denaturation as a marker of human breast tumors.
Kunicka JE; Olszewski W; Rosen PP; Kimmel M; Melamed MR; Darzynkiewicz Z
Cancer Res; 1989 Nov; 49(22):6347-51. PubMed ID: 2804980
[TBL] [Abstract][Full Text] [Related]
18. [Cartilaginous tumors of the skeleton].
Meffert O; Peiper HJ
Chirurg; 1976 Jul; 47(7):392-9. PubMed ID: 954515
[TBL] [Abstract][Full Text] [Related]
19. Expression of c-met proto-oncogene product (c-MET) in benign and malignant bone tumors.
Naka T; Iwamoto Y; Shinohara N; Ushijima M; Chuman H; Tsuneyoshi M
Mod Pathol; 1997 Aug; 10(8):832-8. PubMed ID: 9267827
[TBL] [Abstract][Full Text] [Related]
20. Cytophotometric studies of the DNA, nucleic acid and protein content of human liver cell nuclei.
Ranek L
Acta Cytol; 1976; 20(2):151-7. PubMed ID: 59501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
